UNICA IRIS Institutional Research Information System

PISANU, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 155.138
NA - Nord America 10.302
AS - Asia 4.791
SA - Sud America 1.015
Continente sconosciuto - Info sul continente non disponibili 636
AF - Africa 175
OC - Oceania 42
Totale 172.099
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 152.678
US - Stati Uniti d'America 9.963
SG - Singapore 1.862
CN - Cina 1.371
BR - Brasile 772
SE - Svezia 576
VN - Vietnam 509
GB - Regno Unito 346
DE - Germania 337
FR - Francia 235
FI - Finlandia 228
HK - Hong Kong 211
CA - Canada 192
NL - Olanda 191
BD - Bangladesh 149
IN - India 138
UA - Ucraina 135
AR - Argentina 95
KR - Corea 80
ES - Italia 77
MX - Messico 71
JP - Giappone 70
AT - Austria 54
IQ - Iraq 53
PL - Polonia 49
TR - Turchia 48
ZA - Sudafrica 47
MA - Marocco 45
EC - Ecuador 43
AU - Australia 38
RU - Federazione Russa 37
BE - Belgio 36
CO - Colombia 29
PK - Pakistan 29
ID - Indonesia 25
NO - Norvegia 24
PH - Filippine 24
SA - Arabia Saudita 23
VE - Venezuela 23
IE - Irlanda 22
UZ - Uzbekistan 22
IR - Iran 21
CL - Cile 19
JM - Giamaica 19
MY - Malesia 19
DK - Danimarca 18
CZ - Repubblica Ceca 17
JO - Giordania 17
EG - Egitto 14
KE - Kenya 14
IL - Israele 13
KZ - Kazakistan 13
PY - Paraguay 13
AE - Emirati Arabi Uniti 12
CH - Svizzera 12
TW - Taiwan 12
PT - Portogallo 11
TN - Tunisia 11
DZ - Algeria 10
LT - Lituania 10
AZ - Azerbaigian 9
CR - Costa Rica 7
HN - Honduras 7
NI - Nicaragua 7
OM - Oman 7
PS - Palestinian Territory 7
BO - Bolivia 6
GT - Guatemala 6
KG - Kirghizistan 6
MD - Moldavia 6
NP - Nepal 6
PA - Panama 6
PE - Perù 6
SN - Senegal 6
UY - Uruguay 6
BB - Barbados 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
GE - Georgia 5
QA - Qatar 5
RS - Serbia 5
AM - Armenia 4
BG - Bulgaria 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
NZ - Nuova Zelanda 4
AL - Albania 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
GY - Guiana 3
HR - Croazia 3
KW - Kuwait 3
LB - Libano 3
PR - Porto Rico 3
RO - Romania 3
TT - Trinidad e Tobago 3
CY - Cipro 2
GR - Grecia 2
IS - Islanda 2
Totale 171.419
Salva come PNG Salva come JPEG
Città #
Cagliari 147.490
Uta 4.411
Ashburn 1.136
Singapore 983
San Jose 798
Dallas 797
Fairfield 721
New York 387
Chandler 379
Boardman 357
Woodbridge 341
Houston 331
Seattle 290
Council Bluffs 289
Los Angeles 262
Beijing 261
Nyköping 260
Cambridge 221
Wilmington 221
Santa Clara 191
Hong Kong 183
Ann Arbor 178
The Dalles 173
Helsinki 146
Ho Chi Minh City 144
Hefei 124
Shanghai 124
Lauterbourg 112
Boston 107
Hanoi 106
Rome 89
Dearborn 88
São Paulo 81
Jacksonville 76
Seoul 75
Buffalo 73
Munich 70
Chicago 67
Orem 63
Cardiff 61
Dong Ket 60
Columbus 59
Tokyo 59
Montreal 56
Atlanta 54
Nieuwegein 54
Frankfurt am Main 50
Denver 46
London 46
Milan 45
Nuremberg 45
San Diego 42
Phoenix 41
Warsaw 39
Lappeenranta 38
Redondo Beach 38
Toronto 38
Brooklyn 37
Johannesburg 36
Nanjing 35
Amsterdam 33
Brussels 32
San Francisco 32
Vienna 30
Casablanca 29
Chennai 29
Poplar 29
Stockholm 28
Mexico City 27
Redwood City 27
Guangzhou 26
Rio de Janeiro 25
Da Nang 22
Norwalk 22
Oslo 22
Tianjin 22
Turku 22
Haiphong 19
Changsha 18
Naples 18
Tashkent 18
Aurora 17
Baghdad 17
Manchester 17
Nanchang 17
Rotterdam 17
Belo Horizonte 16
Guayaquil 16
Paris 16
Quito 16
Shenyang 16
Shenzhen 16
Washington 16
Ankara 15
City of London 15
Swansea 15
Amman 14
Biên Hòa 14
Brasília 14
Dublin 14
Totale 164.012
Salva come PNG Salva come JPEG
Nome #
Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients 4.390
Count of “dark telomere” on the track of a biomarker for lithium treatment in bipolar disorder 4.275
Odor identification performance in idiopathic Parkinson’s disease is associated with gender and the genetic variability of the olfactory binding protein 3.710
Major depression subtypes are differentially associated with migraine subtype, prevalence and severity 3.642
Whole Genome Expression Analyses of miRNAs and mRNAs Suggest the Involvement of miR-320a and miR-155-3p and their Targeted Genes in Lithium Response in Bipolar Disorder 3.586
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.524
Challenges and Future Prospects of Precision Medicine in Psychiatry 3.436
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 3.163
Preliminary transcriptome analysis in lymphoblasts from cluster headache and bipolar disorder patients implicates dysregulation of circadian and serotonergic genes 3.064
Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients 3.061
Exploring the role of gut microbiota in major depressive disorder and in treatment resistance to antidepressants 3.028
Convergent analysis of genome-wide genotyping and transcriptomic data suggests association of zinc finger genes with lithium response in bipolar disorder 3.017
Circulating antithyroid antibodies contribute to the decrease of glomerular filtration rate in lithium-treated patients: a longitudinal study 2.996
Exposure and duration of lithium treatment affect leukocyte telomere length in bipolar disorder patients 2.914
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.903
HDAC3 role in medication consumption in medication overuse headache patients: a pilot study 2.831
Involvement of core clock genes in lithium response 2.825
Anterior pituitary autoantibodies in patients with type 1 diabetes mellitus: methodological problems and clinical correlations 2.722
Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease 2.686
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.685
Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: potential involvement of epigenetics 2.677
Increasing engagement in pharmacology and pharmacogenetics education using games and online resources: the PharmacoloGenius mobile app 2.661
Interstitial lung disease induced by fluoxetine: Systematic review of literature and analysis of Vigiaccess, Eudravigilance and a national pharmacovigilance database. 2.607
Sex differences in the response to opioids for pain relief: A systematic review and meta-analysis 2.596
Prediction of Lithium Response using Clinical Data 2.496
High leptin levels are associated with migraine with aura 2.482
Pharmacogenomics of bipolar disorder 2.423
No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample 2.390
Lithium pharmacogenetics: Where do we stand? 2.299
Mood Disorders, Accelerated Aging, and Inflammation: Is the Link Hidden in Telomeres? 2.244
Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder 2.200
null 2.132
Thyroid and renal tumors in patients treated with long-term lithium: case series from a lithium clinic, review of the literature and international pharmacovigilance reports 2.120
Characterisation of age and polarity at onset in bipolar disorder 2.039
An examination of the quality and performance of the Alda scale for classifying lithium response phenotypes 2.012
Efficacia dei farmaci per l’alcolismo: il ruolo della genetica 1.996
MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findings 1.950
Clinical, genetic, and brain imaging predictors of risk for bipolar disorder in high-risk individuals 1.895
Lithium pharmacogenetics 1.864
A genetic risk score is differentially associated with migraine with and without aura 1.858
Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI 1.737
Zinc finger proteins in psychiatric disorders and response to psychotropic medications 1.682
Leukocyte telomere length is reduced in patients with major depressive disorder 1.670
Prediction of lithium response using genomic data 1.664
Presenting Psychiatric and Neurological Symptoms and Signs of Brain Tumors before Diagnosis: A Systematic Review 1.655
Treatment-Resistant Schizophrenia: Insights From Genetic Studies and Machine Learning Approaches 1.611
null 1.572
We are not alone in our body: insights into the involvement of microbiota in the etiopathogenesis and pharmacology of mental illness 1.526
Recent trends on the role of epigenomics, metabolomics and noncoding RNAs in rationalizing mood stabilizing treatment 1.511
PharmacoloGenius: Development of a mobile application to engage in pharmacology 1.483
Telomere length in bipolar disorder and lithium response 1.317
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder 1.289
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 1.279
Investigation of genetic loci shared between bipolar disorder and risk-taking propensity: potential implications for pharmacological interventions 1.244
Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study 1.212
The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine 1.199
A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressants 1.198
Assessment of the pharmacogenomics educational environment in southeast europe 1.192
null 1.156
HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders 1.029
A genome-wide association study of antidepressant-induced mania 999
Gender Differences among Sardinians with Alcohol Use Disorder 961
Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients 843
Sex differences in alcohol use disorder 830
The Xs and Y response to opioids in acute and chronic pain 812
Cost–utility analysis of pharmacogenetic testing based on CYP2C19 or CYP2D6 in major depressive disorder: assessing the drivers of different cost-effectiveness levels from an Italian societal perspective 803
Investigating Shared Genetic Bases between Psychiatric Disorders, Cardiometabolic and Sleep Traits Using K-Means Clustering and Local Genetic Correlation Analysis 801
Involvement of gut microbiota in schizophrenia and treatment resistance to antipsychotics 786
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders 783
Investigation of Genetic Variants Associated with Tryptophan Metabolite Levels via Serotonin and Kynurenine Pathways in Patients with Bipolar Disorder 783
Sex differences in substance use disorders: focus on side effects 783
Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach 742
Correction: Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients (Translational Psychiatry, (2021), 11, 1, (606), 10.1038/s41398-021-01702-2) 738
Association between migraine prevalence, treatment with proton-pump inhibitors and CYP2C19 phenotypes in UK Biobank 738
Is Poor Lithium Response in Individuals with Bipolar Disorder Associated with Increased Degradation of Tryptophan along the Kynurenine Pathway? Results of an Exploratory Study 731
Probing the Association between Cognition, Suicidal Behavior and Tryptophan Metabolism in a Sample of Individuals Living with Bipolar Disorder: A Secondary Analysis 723
Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder 720
Effect of Lithium on gene expression modulation 686
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 683
Pharmacokinetic Markers of Clinical Outcomes in Severe Mental Illness: A Systematic Review 673
Investigating the role of leukocyte telomere length in treatment-resistant depression and in response to electroconvulsive therapy 667
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review 662
Genetic and Epigenetic Markers of Lithium Response 659
Dissecting the genetic overlap between severe mental disorders and markers of cellular aging: Identification of pleiotropic genes and druggable targets 657
An integrated precision medicine approach in major depressive disorder: a study protocol to create a new algorithm for the prediction of treatment response 653
Recommendations for pharmacotranscriptomic profiling of drug response in CNS disorders 600
Analysis on in vitro effect of lithium on telomere length in lymphoblastoid cell lines from bipolar disorder patients with different clinical response to long-term lithium treatment 594
An analysis-ready and quality controlled resource for pediatric brain white-matter research 561
Migraine and gastrointestinal disorders in middle and old age: A UK Biobank study 559
Summaries of plenary, symposia, and oral sessions at the XXII World Congress of Psychiatric Genetics, Copenhagen, Denmark, 12-16 October 2014 512
Melatonin MT1 receptors as a target for the psychopharmacology of bipolar disorder: A translational study 508
Towards precision medicine in psychiatry: investigating the contribution of cellular aging, pleiotropy and gender differences in psychiatric disorders and pharmacological response 499
Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data 494
New insights into the genetic etiology of Alzheimer's disease and related dementias 490
High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysis 489
Genomics yields biological and phenotypic insights into bipolar disorder 470
Plasma stearoyl-coA desaturase activity indices and bile acid concentrations after a low-fat meal: Association with a genetic variant in the FTO gene 460
Squamous-cell carcinoma of the tongue following therapy of rheumatoid arthritis with abatacept 451
A Pilot Interaction Analysis of Gut Microbiota and Peripheral Markers of Aging in Severe Psychiatric Disorders: A Role for Lachnoclostridium? 438
NAFLD is associated with methylation shifts with relevance for the expression of genes involved in lipoprotein particle composition 429
Totale 164.095
Salva come PNG Salva come JPEG
Categoria #
all - tutte 228.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 228.736
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228.387 0 0 0 1.016 990 707 574 508 1.262 1.197 1.204 929
2022/202316.802 960 2.313 2.452 1.529 1.304 1.617 848 1.042 1.211 1.248 1.470 808
2023/202416.375 770 611 612 1.037 1.419 2.565 2.311 1.197 835 1.075 1.958 1.985
2024/202538.024 10.322 11.152 3.920 3.963 2.061 2.347 2.445 163 396 410 319 526
2025/202612.172 940 614 1.489 1.289 1.019 879 1.742 1.012 754 1.393 730 311
2026/20271.853 312 584 780 177 0 0 0 0 0 0 0 0
Totale 172.099